AU4457496A - Use of melatonin for treating patients suffering from drug addiction - Google Patents

Use of melatonin for treating patients suffering from drug addiction

Info

Publication number
AU4457496A
AU4457496A AU44574/96A AU4457496A AU4457496A AU 4457496 A AU4457496 A AU 4457496A AU 44574/96 A AU44574/96 A AU 44574/96A AU 4457496 A AU4457496 A AU 4457496A AU 4457496 A AU4457496 A AU 4457496A
Authority
AU
Australia
Prior art keywords
melatonin
patients suffering
treating patients
drug addiction
addiction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU44574/96A
Other versions
AU695366B2 (en
Inventor
Nava Zisapel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neurim Pharmaceuticals 1991 Ltd
Original Assignee
Neurim Pharmaceuticals 1991 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharmaceuticals 1991 Ltd filed Critical Neurim Pharmaceuticals 1991 Ltd
Publication of AU4457496A publication Critical patent/AU4457496A/en
Application granted granted Critical
Publication of AU695366B2 publication Critical patent/AU695366B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU44574/96A 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction Expired AU695366B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
US381535 1995-02-01
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
EP95303853 1995-06-06
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
AU4457496A true AU4457496A (en) 1996-08-21
AU695366B2 AU695366B2 (en) 1998-08-13

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44574/96A Expired AU695366B2 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0016918A (en) 2000-01-05 2004-03-23 Neurim Pharma 1991 Process and formulation for treating antihypertensive resistance and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
JP2015509106A (en) 2012-01-26 2015-03-26 ヴァンダ ファーマシューティカルズ インコーポレイテッ Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2805376T3 (en) 2012-12-18 2021-02-11 Vanda Pharmaceuticals Inc Tasimelteon for treating circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
EP3337462B1 (en) * 2016-10-31 2020-09-30 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0518468T3 (en) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatonin-containing compositions
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
FI973185A0 (en) 1997-07-31
TR199700723T1 (en) 1998-02-21
LU90118B1 (en) 1997-11-13
CZ291349B6 (en) 2003-02-12
CN1083263C (en) 2002-04-24
MD1716C2 (en) 2002-02-28
BG62876B1 (en) 2000-10-31
PL183148B1 (en) 2002-05-31
WO1996023496A1 (en) 1996-08-08
DK176081B1 (en) 2006-04-18
TW483757B (en) 2002-04-21
JPH10513177A (en) 1998-12-15
BR9607169A (en) 1997-11-11
LV11940B (en) 1998-05-20
DK89697A (en) 1997-07-30
AU695366B2 (en) 1998-08-13
ATA901396A (en) 2001-02-15
NO973531L (en) 1997-09-30
SK284521B6 (en) 2005-05-05
SI9620022A (en) 1998-10-31
CZ240597A3 (en) 1998-01-14
AT408188B (en) 2001-09-25
FI119586B (en) 2009-01-15
SK103097A3 (en) 1998-01-14
MD970254A (en) 1999-05-31
IS1980B (en) 2005-01-14
CN1172431A (en) 1998-02-04
FI973185A (en) 1997-09-30
PL321630A1 (en) 1997-12-08
BG101803A (en) 1998-04-30
MX9705856A (en) 1998-07-31
EE03384B1 (en) 2001-04-16
NO973531D0 (en) 1997-07-31
JP4516159B2 (en) 2010-08-04
NZ298878A (en) 1999-05-28
LV11940A (en) 1998-01-20
EE9700166A (en) 1998-02-16
IS4532A (en) 1997-07-25
NO312814B1 (en) 2002-07-08
MD1716B2 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
AU9028798A (en) Method of improving drug treatment
AU5178296A (en) Induction of e-selectin for targetting therapeutic agents
AU6913796A (en) Patient treatment apparatus
AU4582797A (en) Methods for treatment of retinal diseases
AU5750796A (en) System for the treatment of insomnia
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
AU7012496A (en) Compounds and methods for treatment and diagnosis of prostate cancer
EP1139746A4 (en) Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
HK1001218A1 (en) Use of melatonin for treating patients suffering from drug dependencies
AU2508597A (en) Drug for the treatment of tumours
AU4457496A (en) Use of melatonin for treating patients suffering from drug addiction
AU8869398A (en) Medical apparatus for relief of pain
AU7291996A (en) Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction
AU6485496A (en) Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
AU7484596A (en) Combination therapy for the treatment of diabetes and obesity
AU5713196A (en) Method for treatment of pain
AU6406098A (en) Use of minalcipran and its derivatives for preparing a medicine for treating certain psychiatric diseases
AU7985698A (en) Methods for treatment of ocular neovascularization
GB9524942D0 (en) Drug therapy
AU6126498A (en) Method for the treatment of drug addiction and homeopathic remedy
HUP9900627A3 (en) Use of melatonin for producing pharmaceutical compositions suitable for treating patients suffering from drug addiction
AU5929896A (en) Apparatuses and methods for treatment of blood
AU3632899A (en) Method for the therapeutic and prophylactic treatment of dental diseases
AU7156996A (en) Methods for treatment of interstitial cystitis
AU1014997A (en) A drug for the treatment of cancer